Clinical and mechanistic study on the rate of fistula formation after surgery for perianal abscesses by internal and external orifice sealing method of Lianqi Powder

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083443

Enrollment

Unknown

Registered

2024-04-25

Start date

2024-04-25

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perianal abscess

Interventions

Experimental Group: internal and external orifice sealing method of Lianqi Powder

Control group: internal and external orifice sealing method

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Chinese and Western medical diagnostic criteria for Heat Toxic Type perianal abscess;(2) Age =18 and =60 years old, gender is not limited;(3) Not using other topical drugs for perianal abscess in the past 1 week;(4) Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant or breastfeeding women, allergy and those who are allergic to the drugs involved in this study; (2) Previous history of perianal abscess, anal fistula and other surgical history, or obvious abnormal anal function; (3) Patients with other perianal diseases, such as mixed hemorrhoids and colorectal tumours; (4) Patients with inflammatory bowel disease, such as ulcerative colorectitis and Crohn's disease; (5) Patients with severe primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and haematopoietic systems and psychiatric patients; (6) Patients with delayed wound healing due to infection with tuberculosis, diabetes mellitus, and various consumptive diseases and seeing moderate to severe malnutrition; (7) Participated in or are participating in other clinical trials in the month before enrolment.

Design outcomes

Primary

Measure	Time frame
Postoperative fistula formation rate;	—

Secondary

Measure	Time frame
Wound flora structure;Indicators of wound inflammation;Time to complete wound healing;Incidence of adverse reactions;	—

Countries

China

Contacts

Public ContactWANG Zhenyi

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

drxinhuo@163.com+86 136 0176 0317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026